Respiratory Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Respiratory Assist Devices Pipeline Market Report Overview

Respiratory Assist Devices facilitate breathing during respiratory failure and other respiratory disease conditions. The respiratory assist devices pipeline market research report provides comprehensive information about the respiratory assist devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segment ·       Artificial Lung

·       Respiratory Assist Catheter

Key Territories ·       The US

·       Europe

·       Brazil

·       Israel

·       Japan

Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       Ninsho

Leading Companies ·       ALung Technologies Inc

·       Baxter Healthcare Corp

·       Belluscura Plc

·       Braile Biomedica Ltda

·       Breethe, Inc.

·       Case Western Reserve University

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Respiratory Assist Devices Pipeline Market Segments

Some of the key segments in the respiratory assist devices market are artificial lung and respiratory assist catheters. The artificial lung segment is leading in the market in 2023.

Respiratory Assist Devices Pipeline Market Analysis, by Segments, 2023 (%)

Respiratory Assist Devices Pipeline Market Analysis, by Segments, 2023 (%)

For more segments insights into the respiratory assist devices pipeline market, download a free report sample

Respiratory Assist Devices Pipeline Market Segmentation by Territories

Some of the key territories in the respiratory assist devices market are the US, Europe, Brazil, Israel, and Japan among others. As of June 2023, the US had the highest number of pipeline products.

Respiratory Assist Devices Pipeline Market Analysis, by Territories, 2023 (%)

Respiratory Assist Devices Pipeline Market Analysis, by Territories, 2023 (%)

or more territory insights into the respiratory assist devices pipeline market, download a free report sample

Respiratory Assist Devices Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the respiratory assist devices pipeline market are 510(k), PMA, CE, and Ninsho. As of June 2023, 510(k) was the most followed pathway for pipeline products.

Respiratory Assist Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Respiratory Assist Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the respiratory assist devices pipeline market, download a free report sample

Respiratory Assist Devices Pipeline Market – Competitive Landscape

Some of the key companies in the respiratory assist devices pipeline market are ALung Technologies Inc, Baxter Healthcare Corp, Belluscura Plc, Braile Biomedica Ltda, Breethe, Inc., and Case Western Reserve University among others.

ALung Technologies Inc: ALung Technologies Inc (ALung Technologies) is a medical device company that develops devices for treating patients with acute respiratory failure. The company’s Hemolung Respiratory Assist System(RAS) provides respiratory dialysis that removes carbon dioxide and delivers oxygen directly to the blood which helps to avoid intubation and mechanical ventilation in respiratory exacerbation cases. Its products are used in the treatment of emphysema, asthma with status asthmaticus, chronic bronchitis, acute respiratory failure, and acute respiratory distress syndrome. ALung Technologies’ products are also used in congestive heart failure with pulmonary edema and neonatal respiratory distress syndrome. The company also provides education, service, and support programs. ALung Technologies is headquartered in Pittsburgh, Pennsylvania, the US.

Segments Covered in the Report

Respiratory Assist Devices Pipeline Market Segments Outlook

  • Artificial Lung
  • Respiratory Assist Catheter

Respiratory Assist Devices Pipeline Market Territories Outlook

  • The US
  • Europe
  • Brazil
  • Israel
  • Japan

Respiratory Assist Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • PMA
  • Ninsho

Scope

  • Extensive coverage of the respiratory assist devices under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of respiratory assist devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of respiratory assist devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Advanced Respiratory Technologies LLC
ALung Technologies Inc
Baxter Healthcare Corp
Belluscura Plc
Braile Biomedica Ltda
Breethe, Inc.
Case Western Reserve University
Collplant Biotechnologies Ltd
enmodes GmbH
Liberate Medical LLC
Lung Biotechnology PBC
MAQUET Cardiopulmonary AG
MC3 Inc
McGowan Institute for Regenerative Medicine
Minnesota Health Solutions Corporation
Miromatrix Medical Inc
Postgraduate Institute of Medical Education and Research
Rice University
The Charles Stark Draper Laboratory Inc
TVS Group
U.S. Ann Arbor Healthcare System
University of Arizona
University of California Los Angeles
University of Michigan
University of Pittsburgh
Veterans Health Administration
X-COR Therapeutics
Xenios AG

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Respiratory Assist Devices Overview

  • 3 Products under Development

    • 3.1 Respiratory Assist Devices – Pipeline Products by Stage of Development
    • 3.2 Respiratory Assist Devices – Pipeline Products by Segment
    • 3.3 Respiratory Assist Devices – Pipeline Products by Territory
    • 3.4 Respiratory Assist Devices – Pipeline Products by Regulatory Path
    • 3.5 Respiratory Assist Devices – Pipeline Products by Estimated Approval Date
    • 3.6 Respiratory Assist Devices – Ongoing Clinical Trials

  • 4 Respiratory Assist Devices – Pipeline Products under Development by Companies

    • 4.1 Respiratory Assist Devices Companies – Pipeline Products by Stage of Development
    • 4.2 Respiratory Assist Devices – Pipeline Products by Stage of Development

  • 5 Respiratory Assist Devices Companies and Product Overview

    • 5.1 Advanced Respiratory Technologies LLC Company Overview

      • 5.1.1 Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 ALung Technologies Inc Company Overview

      • 5.2.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Baxter Healthcare Corp Company Overview

      • 5.3.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Belluscura Plc Company Overview

      • 5.4.1 Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Braile Biomedica Ltda Company Overview

      • 5.5.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Breethe, Inc. Company Overview

      • 5.6.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Case Western Reserve University Company Overview

      • 5.7.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Collplant Biotechnologies Ltd Company Overview

      • 5.8.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 enmodes GmbH Company Overview

      • 5.9.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Liberate Medical LLC Company Overview

      • 5.10.1 Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Lung Biotechnology PBC Company Overview

      • 5.11.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 MAQUET Cardiopulmonary AG Company Overview

      • 5.12.1 MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 MC3 Inc Company Overview

      • 5.13.1 MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 McGowan Institute for Regenerative Medicine Company Overview

      • 5.14.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Minnesota Health Solutions Corporation Company Overview

      • 5.15.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Miromatrix Medical Inc Company Overview

      • 5.16.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Postgraduate Institute of Medical Education and Research Company Overview

      • 5.17.1 Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Rice University Company Overview

      • 5.18.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 The Charles Stark Draper Laboratory Inc Company Overview

      • 5.19.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 TVS Group Company Overview

      • 5.20.1 TVS Group Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 U.S. Ann Arbor Healthcare System Company Overview

      • 5.21.1 U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 University of Arizona Company Overview

      • 5.22.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 University of California Los Angeles Company Overview

      • 5.23.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 University of Michigan Company Overview

      • 5.24.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 University of Pittsburgh Company Overview

      • 5.25.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 Veterans Health Administration Company Overview

      • 5.26.1 Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 X-COR Therapeutics Company Overview

      • 5.27.1 X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 Xenios AG Company Overview

      • 5.28.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Respiratory Assist Devices- Recent Developments
  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Respiratory Assist Devices – Pipeline Products by Stage of Development 10

Respiratory Assist Devices – Pipeline Products by Segment 11

Respiratory Assist Devices – Pipeline Products by Territory 12

Respiratory Assist Devices – Pipeline Products by Regulatory Path 13

Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 14

Respiratory Assist Devices – Ongoing Clinical Trials 15

Respiratory Assist Devices Companies – Pipeline Products by Stage of Development 16

Respiratory Assist Devices – Pipeline Products by Stage of Development 18

Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 19

Pulmonary Assist Device – Product Status 19

Pulmonary Assist Device – Product Description 19

ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Hattler Catheter – Product Status 20

Hattler Catheter – Product Description 20

Next Generation Artificial Lung – Product Status 21

Next Generation Artificial Lung – Product Description 21

ULFED – <1L/min – Product Status 21

ULFED – <1L/min – Product Description 22

ULFED – 250 mL/min – Product Status 22

ULFED – 250 mL/min – Product Description 22

Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 23

PrismaLung+ – Product Status 23

PrismaLung+ – Product Description 23

Baxter Healthcare Corp – Ongoing Clinical Trials Overview 24

PrismaLung+ – A Novel ECCO2R Device as a Lung Protective Measure in Hypercapnic Respiratory Failure: A Prospective Multicenter Trial 25

PrismaLung+ – A Post-market Study of Performance and Safety of Low-flow Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Patients with Mild to Moderate Acute Respiratory Distress Syndrome 25

Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview 26

Portable Artificial Lung – Product Status 26

Portable Artificial Lung – Product Description 26

Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 27

Artificial Respirator – Product Status 27

Artificial Respirator – Product Description 27

Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

Abiomed Breethe OXY-1 System – Product Status 28

Abiomed Breethe OXY-1 System – Product Description 29

Breethe, Inc. – Ongoing Clinical Trials Overview 30

Abiomed Breethe OXY-1 System – Breethe Abiomed Recovery Registry (BART) 31

Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 32

Portable Artificial Lung – Product Status 32

Portable Artificial Lung – Product Description 32

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

3D Bioprinted Lung Transplant – Product Status 33

3D Bioprinted Lung Transplant – Product Description 33

enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

RAS-Q – Product Status 34

RAS-Q – Product Description 34

Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

SecondBreath – Product Status 35

SecondBreath – Product Description 35

Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 36

XenoLung – Product Status 36

XenoLung – Product Description 36

MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview 37

PALP – Product Status 37

PALP – Product Description 37

MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview 38

BioLung – Product Status 38

BioLung – Product Description 38

McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 39

A – modELAS – Product Status 39

A – modELAS – Product Description 39

A,P- modELAS – Product Status 40

A,P- modELAS – Product Description 40

Biohybrid Artificial Lung – Product Status 40

Biohybrid Artificial Lung – Product Description 41

Chronic Artificial Lung – Product Status 41

Chronic Artificial Lung – Product Description 41

Impeller Percutaneous Respiratory Assist Catheter (iPRAC) – Product Status 42

Impeller Percutaneous Respiratory Assist Catheter (iPRAC) – Product Description 42

P-modelas – Product Status 42

P-modelas – Product Description 43

Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 44

Non-Invasive Ventilator Respiratory Interface – Product Status 44

Non-Invasive Ventilator Respiratory Interface – Product Description 44

Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Mirolung – Product Status 45

Mirolung – Product Description 45

Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview 46

SMARTS – COVID-19 – Product Status 46

SMARTS – COVID-19 – Product Description 46

Rice University Pipeline Products & Ongoing Clinical Trials Overview 47

Respiratory Assist Device – Product Status 47

Respiratory Assist Device – Product Description 47

The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Silicone-Based Microfluidic Artificial Lung – Product Status 48

Silicone-Based Microfluidic Artificial Lung – Product Description 48

TVS Group Pipeline Products & Ongoing Clinical Trials Overview 49

Sundaram Ventago – Product Status 49

Sundaram Ventago – Product Description 49

U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 50

3D-Printed Artificial Lung – Product Status 50

3D-Printed Artificial Lung – Product Description 50

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 51

HeCOS – Product Status 51

HeCOS – Product Description 51

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 52

Percutaneous Catheter for Lung Assist Device – Product Status 52

Percutaneous Catheter for Lung Assist Device – Product Description 52

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 53

M-Lung – Product Status 53

M-Lung – Product Description 53

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 54

P-PAL – Product Status 54

P-PAL – Product Description 54

Paracorporeal Ambulatory Assist Lung – Product Status 55

Paracorporeal Ambulatory Assist Lung – Product Description 55

Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview 56

3D Printed Microfluidic Artificial Lung – Product Status 56

3D Printed Microfluidic Artificial Lung – Product Description 56

Artificial Lung – Product Status 57

Artificial Lung – Product Description 57

X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 58

Extracorporeal CO2 Removal Device – Product Status 58

Extracorporeal CO2 Removal Device – Product Description 58

Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 59

i-lung – Product Status 59

i-lung – Product Description 59

Glossary 77

Figures

Respiratory Assist Devices – Pipeline Products by Stage of Development 10

Respiratory Assist Devices – Pipeline Products by Segment 11

Respiratory Assist Devices – Pipeline Products by Territory 12

Respiratory Assist Devices – Pipeline Products by Regulatory Path 13

Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 14

Respiratory Assist Devices – Ongoing Clinical Trials 15

Frequently asked questions

Respiratory Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Respiratory Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Respiratory Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Respiratory Assist Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.